These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 17338880

  • 21. Variability and concordance of Cornell and Sokolow-Lyon electrocardiographic criteria in hypertensive patients.
    Vinyoles E, Rodriguez-Blanco T, de la Figuera M, Colomé JM, Tafalla M, Calbet N, Fernández-San Martin MI, García-Alonso J, Murillo C, Agudo J.
    Blood Press; 2012 Dec; 21(6):352-9. PubMed ID: 22587668
    [Abstract] [Full Text] [Related]

  • 22. Prevalence and determinants of electrocardiographic left ventricular hypertrophy among a multiethnic population of postmenopausal women (The Women's Health Initiative).
    Oberman A, Prineas RJ, Larson JC, LaCroix A, Lasser NL.
    Am J Cardiol; 2006 Feb 15; 97(4):512-9. PubMed ID: 16461048
    [Abstract] [Full Text] [Related]

  • 23. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K.
    Circulation; 2012 Jan 17; 125(2):346-53. PubMed ID: 22147903
    [Abstract] [Full Text] [Related]

  • 24. Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement.
    Angeli F, Verdecchia P, Angeli E, Poeta F, Sardone M, Bentivoglio M, Prosciutti L, Cocchieri M, Zollino L, Bellomo G, Rondoni F, Garognoli O, Lenti S, Frigerio C, Gattobigio R, Benemio G, Biscottini B, Panciarola R, Buccolieri M, Liberati R, Trottini M, Cipollini F, Gemelli F, Schillaci G, Porcellati C.
    J Cardiovasc Med (Hagerstown); 2006 Nov 17; 7(11):812-6. PubMed ID: 17060807
    [Abstract] [Full Text] [Related]

  • 25. Sokolow-Lyon voltage criteria in sickle cell patients.
    Foucan L, Haddad A, Genevier I, Samuel Y, Salmi RL.
    West Indian Med J; 1999 Sep 17; 48(3):132-6. PubMed ID: 10555459
    [Abstract] [Full Text] [Related]

  • 26. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG, Omotoso AB, Akande AA.
    Afr J Med Med Sci; 2003 Dec 17; 32(4):395-9. PubMed ID: 15259925
    [Abstract] [Full Text] [Related]

  • 27. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study].
    Martín-Rioboó E, García Criado E, Pérula De Torres LA, Cea-Calvo L, Anguita Sánchez M, López Granados A, Ureña Fernández T, García Matarín L, Molina Díaz R, en representación del Grupo de Hipertensión Arterial de la Sociedad Andaluza de Medicina Familiar y Comunitaria (SAMFyC) y de los investigadores del estudio PREHVIA.
    Med Clin (Barc); 2009 Feb 28; 132(7):243-50. PubMed ID: 19248873
    [Abstract] [Full Text] [Related]

  • 28. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study.
    Niiranen TJ, Jula AM, Kantola IM, Karanko H, Reunanen A.
    J Hum Hypertens; 2007 Oct 28; 21(10):788-94. PubMed ID: 17637793
    [Abstract] [Full Text] [Related]

  • 29. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM, Visseren FLJ, Vernooij JWP, Nathoe HM, Cramer MM, Bemelmans RHH, van der Graaf Y, Spiering W, SMART-study group.
    J Hypertens; 2018 Sep 28; 36(9):1865-1873. PubMed ID: 29878973
    [Abstract] [Full Text] [Related]

  • 30. Relation of central and brachial blood pressure to left ventricular hypertrophy. The Czech Post-MONICA Study.
    Wohlfahrt P, Wichterle D, Seidlerová J, Filipovský J, Bruthans J, Adámková V, Cífková R.
    J Hum Hypertens; 2012 Jan 28; 26(1):14-9. PubMed ID: 21866164
    [Abstract] [Full Text] [Related]

  • 31. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B, LIFE Study Group.
    Hypertension; 2000 Jan 28; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [Abstract] [Full Text] [Related]

  • 32. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G, Olsen MH, Wachtell K, Hille DA, Dahlöf B, Ibsen H, Kjeldsen SE, Lyle PA, Devereux RB.
    J Hum Hypertens; 2007 Aug 28; 21(8):625-32. PubMed ID: 17476291
    [Abstract] [Full Text] [Related]

  • 33. Prevalence of left-ventricular hypertrophy by multiple electrocardiographic criteria in general population: Hermex study.
    Félix-Redondo FJ, Fernández-Bergés D, Calderón A, Consuegra-Sánchez L, Lozano L, Barrios V.
    J Hypertens; 2012 Jul 28; 30(7):1460-7. PubMed ID: 22573128
    [Abstract] [Full Text] [Related]

  • 34. Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.
    Søraas CL, Wachtell K, Okin PM, Dahlöf B, Devereux RB, Tønnessen T, Kjeldsen SE, Olsen MH.
    Blood Press; 2010 Jun 28; 19(3):145-51. PubMed ID: 20429689
    [Abstract] [Full Text] [Related]

  • 35. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R, Light RP.
    Clin J Am Soc Nephrol; 2011 Mar 28; 6(3):528-36. PubMed ID: 21088286
    [Abstract] [Full Text] [Related]

  • 36. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
    Okin PM, Devereux RB, Gerdts E, Snapinn SM, Harris KE, Jern S, Kjeldsen SE, Julius S, Edelman JM, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    Circulation; 2006 Mar 28; 113(12):1588-96. PubMed ID: 16534012
    [Abstract] [Full Text] [Related]

  • 37. Electrocardiographic Left Ventricular Hypertrophy as a Predictor for Nonsignificant Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction.
    Misumida N, Kobayashi A, Saeed M, Fox JT, Kanei Y.
    Angiology; 2016 Jan 28; 67(1):27-33. PubMed ID: 25735856
    [Abstract] [Full Text] [Related]

  • 38. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C, Michey I, Meani S, Severgnini B, Fusi V, Salerno M, Valerio C, Magrini F, Zanchetti A.
    Ital Heart J; 2002 Sep 28; 3(9):514-9. PubMed ID: 12407847
    [Abstract] [Full Text] [Related]

  • 39. [The relationship between isolated nocturnal hypertension and left ventricular hypertrophy].
    Lu L, Li Y, Huang QF.
    Zhonghua Nei Ke Za Zhi; 2008 Oct 28; 47(10):819-22. PubMed ID: 19080140
    [Abstract] [Full Text] [Related]

  • 40. True resistant hypertension: is it possible to be recognized in the office?
    Muxfeldt ES, Bloch KV, Nogueira Ada R, Salles GF.
    Am J Hypertens; 2005 Dec 28; 18(12 Pt 1):1534-40. PubMed ID: 16364821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.